Unknown NA INTERVENTIONAL 3-arm NCT04582721

PREFerred Neurostimulation MODdalities - PREFMOD Study

PREFerred Neurostimulation MODdalities to Treat Chronic Intractable Back Pain, A 3x3 Crossover Study

Sponsor: Ospedale Regionale di Lugano

Interventions Implantable Neurostimulator System (Spectra WaveWriter™ Spinal Cord Stimulator System), (Boston Scientific Neuromodulation Corporation, Valencia, California (CA), USA)

Updated 6 times since 2020 Last updated: Mar 24, 2021 Started: Apr 1, 2019 Primary completion: Apr 9, 2022 Completion: Apr 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04582721, this NA trial focuses on Chronic Low-back Pain and remains ongoing. Sponsored by Ospedale Regionale di Lugano, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jun 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Apr 2021 — Jun 2023 [monthly]

Recruiting NA
Jan 2021 — Apr 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Nov 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ospedale Regionale di Lugano
Paolo Maino MD PhD, Sponsor Investigator

Data source: Ospedale Regionale di Lugano

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lugano, Switzerland